PET/CT影像新技术在青光眼诊断与评估方面的研究进展
The Application Prospect of PET/CT in the Diagnosis and Evaluation of Glaucoma
DOI: 10.12677/HJO.2020.94039, PDF,    科研立项经费支持
作者: 任婉娜, 包宇涵：兰大二院眼科，甘肃 兰州；马金瑞：甘肃省康复中心医院眼科，甘肃 兰州；柳江燕, 崔振存：兰大二院核医学科，甘肃 兰州
关键词: 正电子发射型计算机断层显像；青光眼；视神经损害；PET/CT； Glaucoma； Optic Nerve Damage
摘要: 近年来，人们对青光眼发病机制的了解不断加深，发现了阿尔茨海默病(AD)和青光眼在发病机制上有多种流行病学和组织学重叠。随着影像技术的不断发展，人们应用PET/CT诊断AD积累了一定的经验，用其研究青光眼的发病机制和作为青光眼的早期诊疗评估方法也在进行研究。然而，目前仍有很多问题需要明晰和探索。本文主要对此无创的影像检查在青光眼的诊疗方面的应用进展进行综述。
Abstract: With the development of understanding of the pathogenesis of glaucoma, we find that Alzheimer’s disease (AD) and glaucoma have several epidemiological and histological overlaps in pathogenesis in recent years. Appreciation of the characteristics of PET/CT and their role on Alzheimer’s disease evolves with advances of imaging technology. It is also being explored to study the pathogenesis of glaucoma and as an early diagnosis and treatment method of glaucoma, however, quite a few of questions still need to be further clarified and explored. This article mainly reviews the clinical research and application progress of positron imaging agents in glaucoma.
文章引用：任婉娜, 马金瑞, 包宇涵, 柳江燕, 崔振存. PET/CT影像新技术在青光眼诊断与评估方面的研究进展[J]. 眼科学, 2020, 9(4): 274-279. https://doi.org/10.12677/HJO.2020.94039

参考文献

[1] 张绍丹, 卿国平, 王怀洲, 等. 神经影像学技术在认识青光眼相关的中枢损伤性疾病过程中的作用[J]. 中华眼科医学杂志: 电子版, 2016, 6(2): 93-96.
[2] Romero-Aroca, P., Montero-Jaime, M., Intriago, B., et al. (2012) 18FDG-PET/CT Assessing the Absence of Cell Viability and Excluding Metastatic Disease in a Case of Necrotic Choroidal Melanoma. European Journal of Ophthalmology, 22, 288.
[Google Scholar] [CrossRef] [PubMed]
[3] Dietemann, S., Noblet, V., et al. (2015) FDG PET Findings of the Brain in Sudden Blindness Caused by Bilateral Central Retinal Artery Occlusion Revealing Giant Cell Arteritis. Clinical Nuclear Medicine, 40, 45-46.
[Google Scholar] [CrossRef] 
[4] Deshka, D., Christoph, D., Juergen, H., et al. (2011) The Use of Positron Emission Tomography/CT in the Diagnosis of Tuberculosis-Associated Uveitis. The British Journal of Ophthalmology, 95, 1290-1294.
[Google Scholar] [CrossRef] [PubMed]
[5] 董志章, 李娟, 孙雪荣, 等. TgAPPswePS1转基因鼠视网膜的功能损伤和Aβ斑块沉积[J]. 中华眼视光学与视觉科学杂志, 2018, 20(1): 46-52.
[6] Tsuruma, K., Tanaka, Y., Shimazawa, M., et al. (2010) Induction of Amyloid Precursor Protein by the Neurotoxic Peptide, Amyloid-Beta 25-35, Causes Retinal Ganglion Cell Death. Journal of Neurochemistry, 113, 1545-1554.
[Google Scholar] [CrossRef] [PubMed]
[7] Prakasam, A., Muthuswamy, A., Ablonczy, Z., et al. (2010) Differential Accumulation of Secreted AβPP Metabolites in Ocular Fluids. Journal of Alzheimer’s Disease, 20, 1243-1253.
[Google Scholar] [CrossRef] 
[8] 卢艳, 李臻, 吴越, 张健, 等. 116例正常人房水中阿尔茨海默病生物标志物与年龄相关性研究[J]. 首都医科大学学报, 2017, 38(3): 461-464.
[9] 周金子, 鲁建华, 张文芳. 青光眼患者房水中β淀粉样蛋白的检测[J]. 临床眼科杂志, 2005, 13(3): 202-204.
[10] Rabinovici, G.D., Gatsonis, C., Apgar, C., et al. (2019) Association of Amyloid Positron Emission Tomography with Subsequent Change in Clinical Management among Medicare Beneficiaries with Mild Cognitive Impairment or Dementia. JAMA, 321, 1286-1294.
[Google Scholar] [CrossRef] [PubMed]
[11] Ciarmiello, A., Tartaglione, A., Giovannini, E., et al. (2019) Amyloid Burden Identifies Neuropsychological Phenotypes at Increased Risk of Progression to Alzheimer’s Disease in Mild Cognitive Impairment Patients. European Journal of Nuclear Medicine and Molecular Imaging, 46, 288-296.
[Google Scholar] [CrossRef] [PubMed]
[12] Hatashita, S., Yamasaki, H., Suzuki, Y., et al. (2014) 18F-Flutemetamol Amyloid-Beta PET Imaging Compared with 11C-PIB across the Spectrum of Alzheimer’s Disease. European Journal of Nuclear Medicine & Molecular Imaging, 41, 290-300.
[Google Scholar] [CrossRef] [PubMed]
[13] 任树华, 黄琪, 胡静超, 等. 18F-AV45 PET显像在轻微认知下降和轻度认知障碍患者中的应用[J]. 中华核医学与分子影像杂志, 2020, 40(4): 196-200.
[14] 张晨鹏, 王成, 辛玫, 等. 18F-AV45 PET/CT显像视觉分析及SUVR对不同认知障碍患者的辅助诊断价值[J]. 中华核医学与分子影像杂志, 2020, 40(4): 201-206.
[15] Jia, L., Quan, M., Fu, Y., et al. (2020) Dementia in China: Epidemiology, Clinical Management, and Research Advances. The Lancet Neurology, 19, 81-92.
[Google Scholar] [CrossRef] 
[16] Lin, K.J., Haiao, I.T., Hsu, J.L., et al. (2016) Imaging Characteristic of Dual-Phase 18F-Florbetapir (AV-45/Amyvid) PET for the Concomitant Detection of Perfusion Deficits and Beta-Amyloid Deposition in Alzheimer’s Disease and Mild Cognitive Impairment. European Journal of Nuclear Medicine and Molecular Imaging, 43, 1304-1314.
[Google Scholar] [CrossRef] [PubMed]
[17] D’Estanque, E., Chambert, B., Moranne, O., et al. (2016) 18F-Florbetaben: A New Tool for Amyloidosis Staging. Clinical Nuclear Medicine, 42, 50.
[Google Scholar] [CrossRef] 
[18] Neiberg, M.N. (2009) Alzheimer’s Disease and the Eye. Eye Care Review.
[19] Tamura, H., Kawakami, H., Kanamoto, T., et al. (2006) High Frequency of Open-Angle Glaucoma in Japanese Patients with Alzheimer’s Disease. Journal of the Neurological Sciences, 246, 79-83.
[Google Scholar] [CrossRef] [PubMed]
[20] Sivak, J.M. (2013) The Aging Eye: Common Degenerative Mechanisms between the Alzheimer’s Brain and Retinal Disease. Investigative Ophthalmology & Visual Science, 54, 871-880.
[Google Scholar] [CrossRef] [PubMed]
[21] Sevigny, J., Chiao, P., Bussière, T., et al. (2016) The Antibody Aducanumab Reduces Aβ Plaques in Alzheimer’s Disease. Nature, 537, 50-56.
[Google Scholar] [CrossRef] [PubMed]
[22] López-de-Eguileta, A., Lage, C., López-García, S., et al. (2019) Ganglion Cell Layer Thinning in Prodromal Alzheimer’s Disease Defined by Amyloid PET. Alzheimer’s Dement, 5, 570-578.
[Google Scholar] [CrossRef] [PubMed]
[23] Shimazawa, M., Ito, Y., Inokuchi, Y., et al. (2012) An Alteration in the Lateral Geniculate Nucleus of Experimental Glaucoma Monkeys: In Vivo Positron Emission Tomography Imaging of Glial Activation. PLoS ONE, 7, e30526.
[Google Scholar] [CrossRef] [PubMed]

为你推荐